Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$297K Buy
820
+11
+1% +$3.77K 0.08% 141
2026
Q1
$285K Buy
809
+27
+3% +$9.63K 0.09% 141
2025
Q4
$256K Buy
782
+11
+1% +$3.49K 0.08% 146
2025
Q3
$218K Sell
771
-34
-4% -$9.86K 0.07% 156
2025
Q2
$225K Buy
805
+75
+10% +$21.2K 0.08% 153
2025
Q1
$227K Buy
+730
New +$216K 0.09% 144

Other funds holding AMGN

TFR Capital's AMGN Position: Q2 2026 in Review

TFR Capital increased its Amgen (AMGN) stake by 1.4% in Q2 2026, buying an estimated $3.77K and bringing the position to 820 shares worth $297K. The position accounts for 0.08% of the portfolio, ranked #141.

TFR Capital first reported a position in AMGN in Q1 2025 and has held it in 6 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • TFR Capital held 820 shares of Amgen worth $297K as of Q2 2026.
  • TFR Capital bought 11 Amgen shares in Q2 2026, an estimated $3.77K.
  • Amgen made up 0.08% of TFR Capital's portfolio in Q2 2026, its #141 holding.
  • TFR Capital first reported a position in Amgen in Q1 2025 and has held it in 6 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on TFR Capital's 13F filing for Q2 2026, filed 6 Aug 2026.